Management of hyperkalemia in chronic heart failure using sodium zirconium cyclosilicate

BACKGROUND: Sodium zirconium cyclosilicate (SZC), a newly‐developed selective potassium binder, has been clinically available to treat hyperkalemia. SZC might be a promising option to manage hyperkalemia, particularly in patients with heart failure, who often require potassium‐sparing medications. H...

Descripción completa

Detalles Bibliográficos
Autores principales: Oshima, Akira, Imamura, Teruhiko, Narang, Nikhil, Kinugawa, Koichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2021
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427969/
https://www.ncbi.nlm.nih.gov/pubmed/34263946
http://dx.doi.org/10.1002/clc.23683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427969/
https://www.ncbi.nlm.nih.gov/pubmed/34263946
http://dx.doi.org/10.1002/clc.23683

Ejemplares similares